EGFR and neoplasm: Moreover, in in vivo conditions, the proliferation of subcutaneously implanted A431 xenograft tumor cells lacking DUSP6 was more restricted compared to cells with normal expression of this phosphatase after the action of EGFR inhibitors [77].